Literature DB >> 8546152

Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene.

J Erdmann1, D Shimron-Abarbanell, S Cichon, M Albus, W Maier, D Lichtermann, J Minges, U Reuner, E Franzek, M A Ertl.   

Abstract

In the present study we sought to identify genetic variation in the 5-HT1A receptor gene which through alteration of protein function or level of expression might contribute to the genetic predisposition to neuropsychiatric diseases. Genomic DNA samples from 159 unrelated subjects (including 45 schizophrenic, 46 bipolar affective, and 43 patients with Tourette's syndrome, as well as 25 healthy controls) were investigated by single-strand conformation analysis. Overlapping PCR (polymerase chain reaction) fragments covered the whole coding sequence as well as the 5' untranslated region of the 5-HT1A gene. The region upstream to the coding sequence we investigated contains a functional promoter. We found two rare nucleotide sequence variants. Both mutations are located in the coding region of the gene: a coding mutation (A-->G) in nucleotide position 82 which leads to an amino acid exchange (Ile-->Val) in position 28 of the receptor protein and a silent mutation (C-->T) in nucleotide position 549. The occurrence of the Ile-28-Val substitution was studied in an extended sample of patients (n = 352) and controls (n = 210) but was found in similar frequencies in all groups. Thus, this mutation is unlikely to play a significant role in the genetic predisposition to the diseases investigated. In conclusion, our study does not provide evidence that the 5-HT1A gene plays either a major or a minor role in the genetic predisposition to schizophrenia, bipolar affective disorder, or Tourette's syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546152     DOI: 10.1002/ajmg.1320600509

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

Review 1.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

3.  Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness.

Authors:  Gary M Levin; Toya M Bowles; Megan J Ehret; Taimour Langaee; Jennifer Y Tan; Julie A Johnson; William J Millard
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.

Authors:  Bernadeta Szewczyk; Paul R Albert; Ariel M Burns; Margaret Czesak; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lisa C Konick; Lesa Dieter; Nicole Herbst; Warren May; Grazyna Rajkowska; Craig A Stockmeier; Mark C Austin
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-19       Impact factor: 5.176

Review 5.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.

Authors:  Alexander Neumeister; Theresa Young; Juergen Stastny
Journal:  Psychopharmacology (Berl)       Date:  2004-07-13       Impact factor: 4.530

6.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.

Authors:  Bernd Frank; Beate Niesler; Brigitta Bondy; Michael Späth; Dieter E Pongratz; Manfred Ackenheil; Christine Fischer; Gudrun Rappold
Journal:  Clin Rheumatol       Date:  2004-05-07       Impact factor: 2.980

7.  Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders.

Authors:  J M Hettema; S S An; E J C G van den Oord; M C Neale; K S Kendler; X Chen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-07-05       Impact factor: 3.568

8.  Binding properties of the naturally occurring human 5-HT1A receptor variant with the Ile28Val substitution in the extracellular domain.

Authors:  M Brüss; M Bühlen; J Erdmann; M Göthert; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

Review 9.  The genetics of Tourette syndrome: a review.

Authors:  Julia A O'Rourke; Jeremiah M Scharf; Dongmei Yu; David L Pauls
Journal:  J Psychosom Res       Date:  2009-09-30       Impact factor: 3.006

Review 10.  Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.

Authors:  Paul R Albert; Laura M Fiori
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.